These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37481435)

  • 1. Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial.
    Coulson TG; Miles LF; Zarbock A; Burrell LM; Patel SK; von Groote T; Pilcher D; Weinberg L; Landoni G; Bellomo R
    Br J Anaesth; 2023 Oct; 131(4):664-672. PubMed ID: 37481435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
    Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
    Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
    Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure.
    Boorsma EM; Ter Maaten JM; Damman K; van Veldhuisen DJ; Dickstein K; Anker SD; Filippatos G; Lang CC; Metra M; Santos K; Voors AA
    Eur J Heart Fail; 2021 Jun; 23(6):947-953. PubMed ID: 33742751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery.
    Licker M; Neidhart P; Lustenberger S; Valloton MB; Kalonji T; Fathi M; Morel DR
    Anesthesiology; 1996 Apr; 84(4):789-800. PubMed ID: 8638832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure.
    Kato M; Kinugawa T; Omodani H; Osaki S; Ahmmed GU; Ogino K; Hisatome I; Miyakoda H; Thames MD
    J Card Fail; 1996 Jun; 2(2):103-10. PubMed ID: 8798111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.
    Bokoch MP; Tran AT; Brinson EL; Marcus SG; Reddy M; Sun E; Roll GR; Pardo M; Fields S; Adelmann D; Kothari RP; Legrand M
    BMJ Open; 2023 Nov; 13(11):e078713. PubMed ID: 37984940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
    Trethowan B; Michaud CJ; Fifer S
    Crit Care Med; 2020 Oct; 48(10):e912-e915. PubMed ID: 32931196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association Between Angiotensin II and Renin Kinetics in Patients After Cardiac Surgery.
    Meersch M; Weiss R; Massoth C; Küllmar M; Saadat-Gilani K; Busen M; Chawla L; Landoni G; Bellomo R; Gerss J; Zarbock A
    Anesth Analg; 2022 May; 134(5):1002-1009. PubMed ID: 35171852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normotensive sodium loading in conscious dogs: regulation of renin secretion during beta-receptor blockade.
    Bie P; Mølstrøm S; Wamberg S
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R428-35. PubMed ID: 19073902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
    Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
    Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged infusion of norepinephrine in the conscious dog: effects on blood pressure, heart rate, renin, angiotensin II, and aldosterone.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S114-21. PubMed ID: 6175823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.